ATE230274T1 - Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung - Google Patents

Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung

Info

Publication number
ATE230274T1
ATE230274T1 AT99909234T AT99909234T ATE230274T1 AT E230274 T1 ATE230274 T1 AT E230274T1 AT 99909234 T AT99909234 T AT 99909234T AT 99909234 T AT99909234 T AT 99909234T AT E230274 T1 ATE230274 T1 AT E230274T1
Authority
AT
Austria
Prior art keywords
release preparation
polypeptide
physiologically active
sustained
organic solvent
Prior art date
Application number
AT99909234T
Other languages
English (en)
Inventor
Yutaka Yamagata
Masafumi Misaki
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE230274T1 publication Critical patent/ATE230274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT99909234T 1998-03-20 1999-03-18 Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung ATE230274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7185398 1998-03-20
PCT/JP1999/001359 WO1999048519A1 (en) 1998-03-20 1999-03-18 Sustained-release preparation of physiologically active polypeptide and production thereof

Publications (1)

Publication Number Publication Date
ATE230274T1 true ATE230274T1 (de) 2003-01-15

Family

ID=13472521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909234T ATE230274T1 (de) 1998-03-20 1999-03-18 Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung

Country Status (12)

Country Link
US (1) US6482864B1 (de)
EP (1) EP1061948B1 (de)
KR (1) KR20010042079A (de)
CN (1) CN1301172A (de)
AT (1) ATE230274T1 (de)
AU (1) AU744354B2 (de)
BR (1) BR9908936A (de)
CA (1) CA2324568A1 (de)
DE (1) DE69904701T2 (de)
DK (1) DK1061948T3 (de)
WO (1) WO1999048519A1 (de)
ZA (1) ZA200004597B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383144A1 (en) 1999-09-17 2001-03-29 Takeda Chemical Industries, Ltd. Process for producing protein powder
EP1346722B1 (de) 2000-12-01 2008-12-10 Takeda Pharmaceutical Company Limited Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
US8637077B2 (en) * 2000-12-28 2014-01-28 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2002085399A1 (fr) * 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
EP1413310A1 (de) * 2001-07-09 2004-04-28 Yamanouchi Pharmaceutical Co. Ltd. Zusammensetzungen mit verzögerter freisetzung zur injektion und verfahren zu ihrer herstellung
DE60315472T2 (de) * 2002-09-24 2008-04-30 Asahi Kasei Chemicals Corp. Glycolsaüre copolymer und verfahren zu dessen herstellung
CA2550695A1 (en) * 2003-12-16 2005-06-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Glp-1 pharmaceutical compositions
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
NZ565535A (en) * 2005-06-30 2011-03-31 Ipsen Pharma Sas GLP-1 pharmaceutical compositions
US20070004616A1 (en) * 2005-06-30 2007-01-04 Roland Cherif-Cheikh GLP-1 pharmaceutical compositions
US8071119B2 (en) 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications
WO2010123563A2 (en) * 2009-04-23 2010-10-28 Sustained Nano Systems Llc Controlled release dispensing device
CN102145160A (zh) * 2011-03-07 2011-08-10 深圳市健元医药科技有限公司 一种lhrh拮抗剂注射用的缓释植入制剂
CN102580056B (zh) * 2011-12-16 2014-04-09 深圳市健元医药科技有限公司 一种含抗利尿成分的缓释注射剂及其制备方法
CN113695370B (zh) * 2021-08-30 2022-06-07 河北科技大学 一种天然低共熔离子液体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
DK0432232T3 (da) 1989-05-01 1994-01-31 Alkermes Inc Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
US5478564A (en) 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
FR2658432B1 (fr) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
KR100225983B1 (ko) 1992-10-26 1999-10-15 클라우스-디터 홈메리히, 디트리히 빌헬름 샤흐트 마이크로캡슐의 제조 방법
DK0674506T3 (da) 1992-12-02 2001-01-08 Alkermes Inc Væksthormonholdige mikrosfærer med styret frigivelse
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
WO1997001331A2 (en) * 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
EP0889722B1 (de) 1996-03-28 2002-11-20 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter freisetzung und deren herstellung
ZA9711385B (en) 1996-12-20 1999-06-18 Takeda Chemical Industries Ltd Method of producing a sustained-release preparation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying

Also Published As

Publication number Publication date
DE69904701T2 (de) 2003-11-06
ZA200004597B (en) 2002-02-27
BR9908936A (pt) 2005-10-25
AU2853399A (en) 1999-10-18
US6482864B1 (en) 2002-11-19
AU744354B2 (en) 2002-02-21
EP1061948B1 (de) 2003-01-02
KR20010042079A (ko) 2001-05-25
CA2324568A1 (en) 1999-09-30
DK1061948T3 (da) 2003-03-31
EP1061948A1 (de) 2000-12-27
DE69904701D1 (de) 2003-02-06
CN1301172A (zh) 2001-06-27
WO1999048519A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
DE69904701D1 (de) Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung
DE69420632D1 (de) Verfahren zur Herstellung von Arzneizubereitungen mit verzögerter Wirkstoffabgabe
DE59607548D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
ATE87469T1 (de) Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
DE69719367D1 (de) Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
TR200002059T2 (tr) Devamlı salınan bileşim, üretim yöntemi ve kullanımı.
KR940003540A (ko) 수용성 약제의 마이크로캡슐의 제조방법
DE3481170D1 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung.
HU908477D0 (en) Process for the production of medical preparations with controlled content of active agents
JPS5677259A (en) N-pyridoxyl 5,8,11,14,17-eicosapentaenoic acid amide, and its preparation
OA08170A (fr) Procédé de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues.
ATE243702T1 (de) Verfahren zur herstellung von ascorbinsäurederivaten
EP1258254A4 (de) Zusammensetzungen zur verzögerten abgabe von physiologisch aktiven verbindungen die kaum wasserlösslich sind, verfahren zu deren herstellung und deren verwendung
DE3888943D1 (de) Verfahren zur Verkapselung.
ATE428730T1 (de) Verfahren zur herstellung einer alpha-1- antitrypsinlösung
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
ES2174237T3 (es) Sal sodica del acido (poli-(2-5-dihidroxi-fenilen))-4-tiosulfurico de estructura lineal como regulador del metabolismo celular y su procedimiento de fabricacion.
DE60230298D1 (de) Herstellung von mikropartikeln
JPS645460A (en) Production of delaying gelatinous material
CY1106051T1 (el) ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ Ν-ΠΡΟΣΤΑΤΕΥΜΕΝΩΝ ΑΖΕΤΙΔΙΝΟ-2-ΚΑΡΒΟΞΥΛΙΚΩΝ ΟΞΕΩΝ (AzeOHs)
ATE94766T1 (de) Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllaurophenonoxime (hmlo).
ES8106309A1 (es) Un procedimiento para la preparacion de acido 9-o-metilcla- vulanico
JPS5227739A (en) Process for preparation of 3-substituted or non-substituted-4-hydroxyb enzaldehyde by electrolytic oxidation
UA10180C2 (uk) Спосіб одержання біологічно активної речовини, що має регенераторну та модулюючу дію
DE60039540D1 (de) Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties